CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

25 hedge funds and large institutions have $24.4M invested in Catalyst Pharmaceutical in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
25
Holders Change
+9
Holders Change %
+56.25%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$5.78M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.64M
3
EI
3
EAM Investors
California
$1.36M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$422K
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$309K

Top Sellers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$10M
2
SC
2
Sophrosyne Capital
New York
$732K
3
U
3
UBS
Switzerland
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
CS
5
Credit Suisse
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
U
26
UBS
Switzerland
– -$16K -18,138 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$15K -16,861 Closed
CS
28
Credit Suisse
Switzerland
– -$12K -13,899 Closed
1
2